CGEN

COMPUGEN LTD CGEN

NasdaqSmall CapHealthcare
InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro quality score

Rank #1,356 of 2,925TOP 50%

Why it scores 54Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$72.76M

Quarter to Dec 31

Net income

$35.34M

Quarter to Dec 31

Free cash flow

$31.33M

Quarter to Dec 31

Operating margin

43.0%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$30.30M total
SILVERARC CAPITAL MANAGEMENT, LLC
$6.81M-4.0%
RENAISSANCE TECHNOLOGIES LLC
$4.02M+15.0%
MORGAN STANLEY
$2.25M-0.1%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
$2.18M0.0%
Taylor Frigon Capital Management LLC
$1.80M-0.7%
ARK Investment Management LLC
$1.68M-25.1%
Altshuler Shaham Ltd
$1.12MNew
TWO SIGMA INVESTMENTS, LP
$1.10M-1.8%
STATE STREET CORP
$889.5K+0.1%
Atom Investors LP
$649.5K+569.0%
Yelin Lapidot Holdings Management Ltd.
$603.4K-11.6%
UBS Group AG
$589.9K-10.1%
MILLENNIUM MANAGEMENT LLC
$560.7K+55.1%
AMERICAN CENTURY COMPANIES INC
$457.4KNew
WINTON GROUP Ltd
$421.8K+26.0%
DAFNA Capital Management LLC
$360.0K-34.7%
ROTHSCHILD INVESTMENT LLC
$300.9K0.0%
SRS Capital Advisors, Inc.
$282.1K0.0%
XTX Topco Ltd
$254.8K+79.7%
Cresset Asset Management, LLC
$237.7K0.0%
CITADEL ADVISORS LLC
$221.5K-7.9%
RAYMOND JAMES FINANCIAL INC
$205.7K-8.4%
MATRIX ASSET ADVISORS INC/NY
$200.8K0.0%
OSAIC HOLDINGS, INC.
$178.4K-23.9%
Kingsview Wealth Management, LLC
$178.0K0.0%
See all 83 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Loading ratio trend…

CGEN key financials by period

Reported revenue, net income and operating margin by fiscal year, from COMPUGEN LTD's annual filings on SEC EDGAR.

COMPUGEN LTD reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$72.8M$35.3M43.0%
FY 2024$27.9M$-14.2M-53.4%
FY 2023$33.5M$-18.8M-38.8%
FY 2022$7.5M$-33.7M—
FY 2021$6.0M$-34.2M—
FY 2020$2.0M$-29.7M—
Source: CGEN filings on SEC EDGAR →

Companies similar to CGEN

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

CGEN insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About COMPUGEN LTD (CGEN): stock profile, AI score and financials

COMPUGEN LTD (CGEN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CGEN at 54.0/100 on a composite quality score built from its SEC filings, placing it at rank #1,356 of 2,925 stocks — the top half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), COMPUGEN LTD reports quarterly revenue of $72.8M, net income of $35.3M, an operating margin of 43.0%. Top institutional holders of CGEN by reported 13-F value include SILVERARC CAPITAL MANAGEMENT, RENAISSANCE TECHNOLOGIES, MORGAN STANLEY, based on the most recent SEC filings. CGEN trades on the Nasdaq exchange and files with the SEC under CIK 1119774. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CGEN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for COMPUGEN LTD directly from SEC EDGAR.

SEC EDGAR: CIK 1119774 →